REFERENCES
3. Spear SL, Seruya M. Management of the infected or exposed breast prosthesis: a single surgeon’s 15-year experience with 69 patients. Plast Reconstr Surg. 2010;125:1074-84.
4. Spear SL, Howard MA, Boehmler JH, Ducic I, Low M, Abbruzzesse MR. The infected or exposed breast implant: management and treatment strategies. Plast Reconstr Surg. 2004;113:1634-44.
5. Zhang HL, Cheng Y, Wang XJ. Breast implant infections: clinical microbiology, early diagnosis, and antibiotic treatment. Biomed Environ Sci. 2015;28:472-4.
6. Yii NW, Khoo CT. Salvage of infected expander prostheses in breast reconstruction. Plast Reconstr Surg. 2003;111:1087-92.
7. Zhao R, Tran BNN, Doval AF, et al. A multicenter analysis examining patients undergoing conversion of implant-based breast reconstruction to abdominally based free tissue transfer. J Reconstr Microsurg. 2018;34:685-91.
8. Accurso A, Rocco N, Accardo G, et al. Innovative management of implant exposure in ADM/implant-based breast reconstruction with negative pressure wound therapy. Aesthetic Plast Surg. 2017;41:36-9.
9. Zhang Z, Xin M. Surgical and patient-reported outcomes of autologous versus implant-based reconstruction following infected breast device explantation. Plast Reconstr Surg. 2023;151:688e-9.
10. Albright SB, Xue AS, McKnight A, et al. One-step salvage of infected prosthetic breast reconstructions using antibiotic-impregnated polymethylmethacrylate plates and concurrent tissue expander exchange. Ann Plast Surg. 2016;77:280-5.
11. Marcasciano M, Kaciulyte J, Di Giuli R, et al. “Just pulse it!” introduction of a conservative implant salvage protocol to manage infection in pre-pectoral breast reconstruction: case series and literature review. J Plast Reconstr Aesthet Surg. 2022;75:571-8.
12. Zoccali G, Pozzi M, Gullo P, Michelina VV, Botti C, De Vita R. Regina elena institute (R.E.I.) protocol for breast implant salvage: preliminary results. Clin Breast Cancer. 2024;24:65-71.
13. Basta MN, Liu PY, Kwan D, et al. Improved diagnostic accuracy of periprosthetic breast infection: novel application of the alpha defensin-1 biomarker. Plast Reconstr Surg Glob Open. 2019;7:e2542.
14. Basta MN, White-Dzuro CG, Rao V, et al. Alpha defensin-1 biomarker outperforms culture in diagnosing breast implant-related infection: results from a multicenter prospective study. Plast Reconstr Surg. 2023;151:706-14.
15. Knackstedt R, Scomacao I, Djohan R. Utilization of irrigating negative pressure wound therapy for breast implant salvage: long-term results and success. J Plast Reconstr Aesthet Surg. 2021;74:407-47.
16. Caputo GG, Scarabosio A, Di Filippo J, et al. Redefining infection management in implant-based breast reconstruction: insights and innovations from an 11-year retrospective analysis. J Plast Reconstr Aesthet Surg. 2025;100:82-92.
17. Pardo J, Klinker KP, Borgert SJ, Butler BM, Giglio PG, Rand KH. Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. Diagn Microbiol Infect Dis. 2016;84:159-64.
18. Meybodi F, Sedaghat N, Elder E, et al. Salvaging the unsalvageable: negative pressure wound therapy for severe infection of prosthetic breast reconstruction. Plast Reconstr Surg Glob Open. 2021;9:e3456.
19. Ahmed S, Hulsman L, Imeokparia F, et al. Implant-based breast reconstruction salvage with negative pressure wound therapy with instillation: an evaluation of outcomes. Plast Reconstr Surg Glob Open. 2024;12:e6116.
20. Gruener JS, Horch RE, Geierlehner A, et al. Is instillational topical negative pressure wound therapy in peri-prosthetic infections of the breast effective? A pilot study. J Pers Med. 2022;12:2054.
21. O’Connor MJ, Huffman KN, Ho K, et al. Negative pressure wound therapy with instillation for periprosthetic infection after breast reconstruction: a systematic review. Plast Reconstr Surg Glob Open. 2024;12:e6267.
22. Brown OH, Danko D, Muret-Wagstaff SL, et al. Close the GAPS: a standardized perioperative protocol reduces breast reconstruction implant infections. Plast Reconstr Surg. 2023;152:1175-84.
23. Barr SP, Topps AR, Barnes NL, et al; Northwest Breast Surgical Research Collaborative. Infection prevention in breast implant surgery - a review of the surgical evidence, guidelines and a checklist. Eur J Surg Oncol. 2016;42:591-603.
24. Zhang R, Singh D, Parsa FD. Review of early signs of breast implant infection. Aesthetic Plast Surg. 2022;46:2152-8.
25. Esteban J, Salar-Vidal L, Schmitt BH, et al. Multicenter evaluation of the BIOFIRE Joint Infection Panel for the detection of bacteria, yeast, and AMR genes in synovial fluid samples. J Clin Microbiol. 2023;61:e0035723.
26. BIOMERIEUX. BIOFIRE® Joint Infection (JI) Panel. Available from: https://www.biomerieux.com/us/en/our-offer/clinical-products/biofire-joint-infection-panel.html. [Last accessed on 28 May 2025].
27. Campbell CA. The role of Triple-Antibiotic saline irrigation in breast implant surgery. Ann Plast Surg. 2018;80:S398-402.
28. Bhardwaj S, Mehra P, Dhanjal DS, et al. Antibiotics and antibiotic resistance- flipsides of the same coin. Curr Pharm Des. 2022;28:2312-29.
29. Feldman EM, Kontoyiannis DP, Sharabi SE, Lee E, Kaufman Y, Heller L. Breast implant infections: is cefazolin enough? Plast Reconstr Surg. 2010;126:779-85.
30. Rezende-Pereira G, Albuquerque JP, Souza MC, et al. Biofilm formation on breast implant surfaces by major gram-positive bacterial pathogens. Aesthet Surg J. 2021;41:1144-51.
31. Vyas S, Patel D, Bandali A, Giordano P, Roland R, Kessler J. Impact of BioFire® Blood Culture Identification (BCID) panels on antibiotic management of bacteremia due to select organisms. Diagn Microbiol Infect Dis. 2024;110:116384.
